TransMedics Group, Inc. — Director's Dealing 2024

Mar 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-03-08

Reporting Person: Khayal Tamer I (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-08	Common Stock	M	100	$16.14	Acquired	26602	Direct
2024-03-08	Common Stock	S	100	$90.04	Disposed	26502	Direct
2024-03-08	Common Stock	S	1317	$87.63	Disposed	25185	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-08	Stock Option (Right to Buy)	$16.14	M	100	Disposed	2030-02-27	Common Stock (100)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14776	Indirect
Common Stock	11051	Indirect

Footnotes

F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

F3: The option is fully vested.